Ethics & Responsible Innovation Review Checklist

Purpose

This checklist helps teams pause before trials or prototypes to identify and manage likely ethical, social, privacy, bias, safety, and environmental harms. Use it to prompt concrete actions, produce simple artifacts to support review, and decide whether to proceed, revise, limit scope, or stop.

How to use this checklist

Work through each section with the smallest cross-functional team that understands the project (product lead, researcher/engineer, legal or compliance advisor when available, privacy or data lead, and a representative of impacted stakeholders when possible). For each checklist item, add a short note, evidence, or reference to a document. If an item is a concern, mark it and propose a mitigation or an escalation.

Quick decision guidance

• No major unresolved harms: Proceed with monitoring and documented mitigations.
• Manageable harms with mitigations: Proceed to a controlled pilot with explicit safeguards and monitoring metrics.
• Unresolved high-severity harms: Pause and escalate to the ethics review body; require redesign or stop.

Checklist

1. Define scope & beneficiaries
   • Describe the feature, experiment, or trial in plain language and its intended beneficiaries.
   • List who could be affected (direct and indirect users, bystanders, communities, environment).
   • Attach a one-page Stakeholder Impact Map or link to where it is stored.
2. Consent, notice & expectations
   • Is data collection transparent to affected people? (Yes/No) — If no, explain why and propose a mitigation.
   • Do participants provide informed consent appropriate to the context and vulnerability of populations involved?
   • Have you documented how expectations will be set and how participants can opt-out or withdraw?
3. Data privacy & minimization
   • List data types collected and retention period.
   • Apply data minimization: can any field be removed or aggregated? (Yes/No)
   • Is data pseudonymized or encrypted at rest and in transit? Note controls and owners.
4. Fairness, bias & representativeness
   • Have you considered groups that may be underrepresented or harmed? Provide examples.
   • List potential bias sources (data, labels, sampling, model assumptions, deployment context).
   • Planned fairness checks or metrics (e.g., subgroup performance, disparate impact tests).
5. Safety, reliability & unintended behaviors
   • Enumerate ways the system could fail or be misused and the likely consequences.
   • Is there a clear rollback or kill-switch for the trial? Who has authority to trigger it?
   • Describe monitoring and anomaly detection for the trial period.
6. Legal, regulatory & compliance checks
   • Identify applicable laws, regulations, standards, or contractual obligations.
   • Note areas requiring legal or domain expert review (privacy law, clinical safety, child protection, export controls).
7. Environmental & sustainability impacts
   • Estimate material environmental impacts (energy use, hardware footprint, waste).
   • Is there a plan to minimize environmental harm or offset impacts during trials?
8. Equity, accessibility & dignity
   • Does the design respect cultural norms and human dignity? Note potential harms.
   • Is the experience accessible to people with disabilities? Have accessibility checks been run?
9. Remediation & redress
   • Is there a documented remediation plan if harm occurs? Include contact points and timelines.
   • How will affected people be notified and given redress or correction?
10. Transparency & documentation
    • Attach or link to a short Ethics Note, Data Dictionary, and Risk Register for the trial.
    • Document decision owners, review dates, and how public the documentation should be.
11. Monitoring, metrics & evaluation
    • Define success, safety, and harm metrics and their thresholds for action.
    • State cadence for review and responsible reviewers during the trial.
12. Stakeholder engagement & feedback
    • Plan for collecting stakeholder feedback during the pilot (surveys, interviews, feedback channels).
    • How will feedback be incorporated? Who signs off on changes?
13. Escalation & decision
    • If unresolved high-severity risks exist, escalate to: [Ethics Review Board / Compliance Lead / Product Council] with summary and artifacts.
    • Decision options to record: Proceed / Proceed with Mitigations / Restrict Scope / Pause / Stop.

Suggested documentation to attach

• Stakeholder Impact Map
• Short Ethics Note (1–2 pages)
• Data Dictionary and Retention Plan
• Risk Register with severity and likelihood
• Monitoring plan and metrics dashboard links
• Remediation & communication plan

Roles & responsibilities (example)

• Project Lead: completes checklist and owns attachments.
• Data/Privacy Lead: verifies data controls and minimization.
• Engineering/Research Lead: identifies failure modes and rollback mechanisms.
• Ethics/Compliance Reviewer: provides independent review and escalation when required.

After the trial

Document outcomes, update the Risk Register, capture lessons learned, and record any design or policy changes made because of the trial.

Notes & limitations

This checklist supports practical, early-stage governance. It does not replace legal, clinical, or domain-specific expert review. Use it to reduce false assurance and to make timely, documented decisions about ethical risks.